32 results on '"MU, YIMING"'
Search Results
2. Diabetic microenvironment preconditioning of adipose tissue-derived mesenchymal stem cells enhances their anti-diabetic, anti-long-term complications, and anti-inflammatory effects in type 2 diabetic rats
- Author
-
Su, Wanlu, Yu, Songyan, Yin, Yaqi, Li, Bing, Xue, Jing, Wang, Jie, Gu, Yulin, Zhang, Haixia, Lyu, Zhaohui, Mu, Yiming, and Cheng, Yu
- Published
- 2022
- Full Text
- View/download PDF
3. Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events
- Author
-
Yang, Yang, Peng, Nianchun, Chen, Gang, Wan, Qin, Yan, Li, Wang, Guixia, Qin, Yingfen, Luo, Zuojie, Tang, Xulei, Huo, Yanan, Hu, Ruying, Ye, Zhen, Qin, Guijun, Gao, Zhengnan, Su, Qing, Mu, Yiming, Zhao, Jiajun, Chen, Lulu, Zeng, Tianshu, Yu, Xuefeng, Li, Qiang, Shen, Feixia, Chen, Li, Zhang, Yinfei, Wang, Youmin, Deng, Huacong, Liu, Chao, Wu, Shengli, Yang, Tao, Li, Mian, Xu, Yu, Xu, Min, Zhao, Zhiyun, Wang, Tiange, Lu, Jieli, Bi, Yufang, Wang, Weiqing, Ning, Guang, Zhang, Qiao, and Shi, Lixin
- Published
- 2022
- Full Text
- View/download PDF
4. Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study.
- Author
-
Li, Binqi, Liu, Yang, Zhou, Xin, Gu, Weijun, and Mu, Yiming
- Subjects
CHINESE people ,REGRESSION analysis ,DIABETES ,CHOLESTEROL ,SENSITIVITY analysis - Abstract
Aims: Very few cohort studies are available about the relation between remnant cholesterol (RC) and diabetes. Based on a prospective cohort survey, this research aimed at investigating if high RC was related to a future diabetes risk in the Chinese population, as well as to compare the association between RC, high‐density lipoprotein cholesterol (HDL‐C), low‐density lipoprotein cholesterol (LDL‐C), total cholesterol (TC), triglycerides (TG), TG/HDL‐C, LDL‐C/HDL‐C, TC/HDL‐C, and non‐high‐density lipoprotein cholesterol (non‐HDL‐C), and future diabetes risk. Materials and Methods: 6,700 baseline normoglycemic participants of the REACTION study's Beijing center were recruited in 2011–2012 and followed up in 2015. Multivariate Cox regression analyses were performed to explore the relationship of RC, HDL‐C, LDL‐C, TC, TG, LDL‐C/HDL‐C, TG/HDL‐C, TC/HDL‐C, and non‐HDL‐C and a future diabetes risk. Results: After potential confounders were adjusted for, only RC (HR 1.134, 95% CI 1.016–1.267, P = 0.025) was positively related to a future diabetes risk, and only HDL‐C (HR 0.728, 95% CI 0.578–0.918, P = 0.007) was negatively related to a future diabetes risk. The rest of the lipid parameters were not related to a future risk of diabetes. Sensitivity and stratification analyses revealed that the relation between RC and future diabetes risk was stable. RC and future diabetes risk were still positively correlated even when the HDL‐C was ≥1.04 mmol/L (HR 1.167, 95% CI 1.050–1.297, P = 0.004). Conclusions: It was RC, but not other lipid parameters, that was independently and positively related to a future risk of diabetes among the Chinese general population. Moreover, the relationship between RC and diabetes risk was stable, even with appropriate levels of HDL‐C. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Clinical characteristics and complication risks in data‐driven clusters among Chinese community diabetes populations.
- Author
-
Li, Binqi, Yang, Zizhong, Liu, Yang, Zhou, Xin, Wang, Weiqing, Gao, Zhengnan, Yan, Li, Qin, Guijun, Tang, Xulei, Wan, Qin, Chen, Lulu, Luo, Zuojie, Ning, Guang, Gu, Weijun, and Mu, Yiming
- Subjects
GLYCOSYLATED hemoglobin ,GLYCEMIC control ,DIABETES complications ,LOGISTIC regression analysis ,CHRONIC kidney failure - Abstract
Background: Novel diabetes phenotypes were proposed by the Europeans through cluster analysis, but Chinese community diabetes populations might exhibit different characteristics. This study aims to explore the clinical characteristics of novel diabetes subgroups under data‐driven analysis in Chinese community diabetes populations. Methods: We used K‐means cluster analysis in 6369 newly diagnosed diabetic patients from eight centers of the REACTION (Risk Evaluation of cAncers in Chinese diabeTic Individuals) study. The cluster analysis was performed based on age, body mass index, glycosylated hemoglobin, homeostatic modeled insulin resistance index, and homeostatic modeled pancreatic β‐cell functionality index. The clinical features were evaluated with the analysis of variance (ANOVA) and chi‐square test. Logistic regression analysis was done to compare chronic kidney disease and cardiovascular disease risks between subgroups. Results: Overall, 2063 (32.39%), 658 (10.33%), 1769 (27.78%), and 1879 (29.50%) populations were assigned to severe obesity‐related and insulin‐resistant diabetes (SOIRD), severe insulin‐deficient diabetes (SIDD), mild age‐associated diabetes mellitus (MARD), and mild insulin‐deficient diabetes (MIDD) subgroups, respectively. Individuals in the MIDD subgroup had a low risk burden equivalent to prediabetes, but with reduced insulin secretion. Individuals in the SOIRD subgroup were obese, had insulin resistance, and a high prevalence of fatty liver, tumors, family history of diabetes, and tumors. Individuals in the SIDD subgroup had severe insulin deficiency, the poorest glycemic control, and the highest prevalence of dyslipidemia and diabetic nephropathy. Individuals in MARD subgroup were the oldest, had moderate metabolic dysregulation and the highest risk of cardiovascular disease. Conclusion: The data‐driven approach to differentiating the status of new‐onset diabetes in the Chinese community was feasible. Patients in different clusters presented different characteristics and risks of complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample survey.
- Author
-
Li, Binqi, Liu, Yang, Zhou, Xin, Chen, Lulu, Yan, Li, Tang, Xulei, Gao, Zhengnan, Wan, Qin, Luo, Zuojie, Qin, Guijun, Ning, Guang, Gu, Weijun, and Mu, Yiming
- Subjects
MULTIPLE regression analysis ,LOGISTIC regression analysis ,PREDIABETIC state ,INSULIN resistance ,DIABETES - Abstract
Background: Not many large‐sample investigations are available that compare the potency of the relationship of remnant cholesterol (RC) and other lipid parameters with diabetes and prediabetes. The goals of our study are to discover the relationship between RC and prediabetes, diabetes, and insulin resistance (IR) and to investigate RC, high‐density lipoprotein cholesterol (HDL‐C), non‐HDL‐C, triglycerides (TG), low‐density lipoprotein cholesterol (LDL‐C), total cholesterol (TC), TC/HDL‐C, LDL‐C/HDL‐C, and TG/HDL‐C, which are the lipid parameters that are most positively related to diabetes, prediabetes, and IR. Methods: This research enrolled 36 684 subjects from China's eight provinces. We employed multiple logistic regression analysis for testing the relationship between lipid parameters and diabetes, prediabetes, and IR. Results: After adjusting for potential confounders, and comparing the results with other lipid parameters, the positive relationship between RC and diabetes (odds ratio [OR] 1.417, 95% confidence interval [CI]: 1.345–1.492), prediabetes (OR 1.555, 95% CI: 1.438–1.628), and IR (OR 1.488, 95% CI: 1.404–1.577) was highest. RC was still related to diabetes, prediabetes, and IR even when TG <2.3 mmol/L (diabetes: OR 1.256, 95% CI: 1.135–1.390; prediabetes: OR 1.503, 95% CI: 1.342–1.684; and IR: OR 1.278, 95% CI: 1.140–1.433), LDL‐C <2.6 mmol/L (diabetes: OR 1.306, 95% CI: 1.203–1.418; prediabetes: OR 1.597, 95% CI: 1.418–1.798; and IR: OR 1.552, 95% CI: 1.416–1.701), or HDL‐C ≥1 mmol/L (diabetes: OR 1.456, 95% CI: 1.366–1.550; prediabetes: OR 1.553, 95% CI: 1.421–1.697; and IR: OR 1.490, 95% CI: 1.389–1.598). Conclusion: RC is more positively related to diabetes, prediabetes, and IR than conventional lipids and lipid ratios in the general population, the relationships between RC and diabetes, prediabetes, and IR are stable, even if HDL‐C, LDL‐C, or TG are at appropriate levels. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Critical appraisal and systematic review of guidelines for perioperative diabetes management: 2011–2017
- Author
-
Song, Xiaoyang, Wang, Jinjing, Gao, Yuting, Yu, Yang, Zhang, Jingyi, Wang, Qi, Ma, Xiaoting, Estille, Janne, Jin, Xinye, Chen, Yaolong, and Mu, Yiming
- Published
- 2019
- Full Text
- View/download PDF
8. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats
- Author
-
Yu, Songyan, Cheng, Yu, Zhang, Linxi, Yin, Yaqi, Xue, Jing, Li, Bing, Gong, Zhengyuan, Gao, Jieqing, and Mu, Yiming
- Published
- 2019
- Full Text
- View/download PDF
9. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice
- Author
-
Gao, Jieqing, Cheng, Yu, Hao, Haojie, Yin, Yaqi, Xue, Jing, Zhang, Qi, Li, Lin, Liu, Jiejie, Xie, Zongyan, Yu, Songyan, Li, Bing, Han, Weidong, and Mu, Yiming
- Published
- 2019
- Full Text
- View/download PDF
10. Osteopenia is associated with glycemic levels and blood pressure in Chinese postmenopausal women: a cross-sectional study
- Author
-
Sun, Qihong, Zheng, Yu, Chen, Kang, Yan, Wenhua, Lu, Juming, Dou, Jingtao, Lv, Zhaohui, Wang, Baoan, Gu, Weijun, Ba, Jianming, and Mu, Yiming
- Published
- 2017
- Full Text
- View/download PDF
11. Remnant cholesterol is independently associated with diabetes, even if the traditional lipid is at the appropriate level: A report from the REACTION study.
- Author
-
Li, Binqi, Zhou, Xin, Wang, Weiqing, Gao, Zhengnan, Yan, Li, Qin, Guijun, Tang, Xulei, Wan, Qin, Chen, Lulu, Luo, Zuojie, Ning, Guang, and Mu, Yiming
- Subjects
LDL cholesterol ,HDL cholesterol ,DIASTOLIC blood pressure ,SYSTOLIC blood pressure ,CHOLESTEROL - Abstract
Copyright of Journal of Diabetes is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
12. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study.
- Author
-
Wang, Tiange, Li, Mian, Zeng, Tianshu, Hu, Ruying, Xu, Yu, Xu, Min, Zhao, Zhiyun, Chen, Yuhong, Wang, Shuangyuan, Lin, Hong, Yu, Xuefeng, Chen, Gang, Su, Qing, Mu, Yiming, Chen, Lulu, Tang, Xulei, Yan, Li, Qin, Guijun, Wan, Qin, and Gao, Zhengnan
- Subjects
OBESITY complications ,OBESITY ,CARDIOVASCULAR diseases ,DIABETES ,BLOOD sugar ,PREDIABETIC state ,INSULIN resistance ,LONGITUDINAL method ,DISEASE complications - Abstract
Objective: To investigate whether the association between insulin resistance and cardiovascular disease (CVD) differs by glucose tolerance status.Research Design and Methods: We analyzed a nationwide sample of 111,576 adults without CVD at baseline, using data from the China Cardiometabolic Disease and Cancer Cohort Study. Insulin resistance was estimated by sex-specific HOMA of insulin resistance (HOMA-IR) quartiles for participants with normal glucose tolerance, prediabetes, or diabetes, separately, and by 1 SD of HOMA-IR for the overall study participants. We used Cox proportional hazards models to examine the association between insulin resistance and incident CVD according to glucose tolerance status and evaluate the CVD risk associated with the combined categories of insulin resistance and obesity in prediabetes and diabetes, as compared with normal glucose tolerance. Models were adjusted for age, sex, education attainment, alcohol drinking, smoking, physical activity, and diet quality.Results: In participants with normal glucose tolerance, prediabetes, and diabetes defined by three glucose parameters, multivariable-adjusted hazard ratios (95% CIs) for incident CVD associated with the highest versus the lowest quartile of HOMA-IR were 1.03 (0.82-1.30), 1.23 (1.07-1.42), and 1.61 (1.30-2.00), respectively; the corresponding values for CVD per 1-SD increase in HOMA-IR were 1.04 (0.92-1.18), 1.12 (1.06-1.18), and 1.15 (1.09-1.21), respectively (P for interaction = 0.011). Compared with participants with normal glucose tolerance, in participants with prediabetes, the combination of the highest HOMA-IR quartile and obesity showed 17% (95% CI 2-34%) higher risk of CVD, while the combination of the lowest two HOMA-IR quartiles and nonobesity showed 15-17% lower risk of CVD. In participants with diabetes, the upper two HOMA-IR quartiles exhibited 44-77% higher risk of CVD, regardless of obesity status. Consistent findings were observed for glucose tolerance status defined by different combinations of glycemic parameters.Conclusions: Glucose intolerance status exacerbated the association between insulin resistance and CVD risk. Compared with adults with normal glucose tolerance, adults with prediabetes who were both insulin resistant and obese exhibited higher risks of CVD, while in adults with diabetes, the CVD risk related to insulin resistance remained, regardless of obesity. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
13. Plasma homocysteine thiolactone associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus
- Author
-
Gu, Weijun, Lu, Juming, Yang, Guoqing, Dou, Jingtao, Mu, Yiming, Meng, Junhua, and Pan, Changyu
- Published
- 2008
- Full Text
- View/download PDF
14. High Normal Urinary Albumin–Creatinine Ratio Is Associated With Hypertension, Type 2 Diabetes Mellitus, HTN With T2DM, Dyslipidemia, and Cardiovascular Diseases in the Chinese Population: A Report From the REACTION Study.
- Author
-
Wang, Jie, Wang, Yun, Li, Yijun, Hu, Ying, Jin, Lingzi, Wang, Weiqing, Gao, Zhengnan, Tang, Xulei, Yan, Li, Wan, Qin, Luo, Zuojie, Qin, Guijun, Chen, Lulu, Gu, Weijun, Lyv, Zhaohui, and Mu, Yiming
- Subjects
TYPE 2 diabetes ,CARDIOVASCULAR diseases ,CHINESE people ,DYSLIPIDEMIA ,PROPENSITY score matching - Abstract
Background: Albuminuria has been widely considered a risk factor for cardiovascular diseases (CVDs), which is associated with hypertension (HTN), type 2 diabetes mellitus (T2DM), HTN with T2DM, and dyslipidemia. However, the associations between albuminuria and HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs are still unclear. Thus, this study aimed to explore the association of albuminuria thoroughly, especially within the normal range, with the abovementioned diseases in the Chinese population. Methods: This study included 40,188 participants aged over 40 years from seven centers across China. Urinary albumin–creatinine ratio (UACR) was firstly divided into the ≥30-mg/g group, indicating kidney damage, and <30-mg/g group. Furthermore, UACR was divided into five groups: the <20%, 20%–39%, 40%–59%, 60%–79%, and ≥80% groups, according to the quintile division of participants within the normal range. Propensity score matching was used to reduce bias, and multiple logistic regression models were conducted to examine the association between UACR and HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs. Results: Multivariable regression analysis revealed that UACR, even within the normal range, is significantly associated with HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs, and the association between UACR and HTN with T2DM was the most significant in model 3 even after adjusting for confounding factors (HTN: OR = 1.56 (95% CI = 1.45–1.68), p < 0.0001; T2DM: OR = 1.78 (95% CI = 1.60–1.97), p < 0.0001; HTN with T2DM: OR = 1.76 (95% CI = 1.59–1.95), p < 0.0001; dyslipidemia: OR = 1.08 (95% CI = 1.01–1.14), p = 0.0146; CVDs: OR = 1.12 (95% CI = 1.00–1.25), p = 0.0475). In the stratified analysis, high normal UACR was significantly associated with HTN, T2DM, HTN with T2DM, and dyslipidemia in subgroups. Conclusions: In summary, we observe a higher prevalence of HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs in abnormal UACR and reveal a significant association of UACR, even within the normal range, with HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Fatty liver index for hyperuricemia diagnosis: a community-based cohort study.
- Author
-
Qu, Jianchang, Dou, Jingtao, Wang, Anping, Liu, Yingshu, Lin, Lu, Chen, Kang, Zang, Li, and Mu, Yiming
- Subjects
LIPID metabolism ,HYPERURICEMIA ,HYPERTENSION ,FATTY liver ,ANTHROPOMETRY ,DIABETES ,RISK assessment ,URIC acid ,SENSITIVITY & specificity (Statistics) ,INSULIN resistance ,LONGITUDINAL method - Abstract
Background: Studies have demonstrated the relationship between the fatty liver index (FLI) and metabolism, while few research reported its relationship with hyperuricemia (HUA). This study aimed to predict HUA by determining the relationship between the baseline FLI and HUA events and by validating the FLI–HUA correlation through follow-up. Methods: This study was a community-based cohort study involving 8851 adults in China. We performed anthropometric assessments and analyzed baseline and follow-up blood samples. HUA was defined as a uric acid level of > 420 µmol/L (7 mg/dL). Results: Patients with HUA had a higher prevalence of diabetes mellitus, lipid metabolism disorders, and hypertension and higher FLI values than those with normal uric acid levels (P < 0.001). Serum uric acid was positively correlated with the FLI (r = 0.41, P < 0.001); the diagnostic cut-off value of FLI for the diagnosis of HUA was 27.15, with a specificity of 70.9% and sensitivity of 79.6%. FLI was an independent risk factor for HUA, with a 1.72-, 2.74-, and 4.80-fold increase in the risk of developing HUA with increasing FLI quartile levels compared with the FLI at quartile level 1 (P < 0.001). After a mean follow-up of 4 years, as the FLI values increased compared with the FLI at quartile level 1, the risk of new-onset HUA increased by 3.10-, 4.89-, and 6.97-fold (P < 0.001). Conclusion: There is a higher incidence of metabolic abnormalities in HUA populations, and FLI is an independent factor that may contribute to HUA development. Therefore, FLI is a potential tool to predict the risk of developing HUA. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Insights Into Genome-Wide Association Study for Diabetes: A Bibliometric and Visual Analysis From 2001 to 2021.
- Author
-
Liu, Yang, Wang, Yun, Qin, Shan, Jin, Xinye, Jin, Lingzi, Gu, Weijun, and Mu, Yiming
- Subjects
GENOME-wide association studies ,TYPE 2 diabetes ,ETIOLOGY of diabetes ,BIBLIOMETRICS ,GENETIC variation - Abstract
Hundreds of research and review articles concerning genome-wide association study (GWAS) in diabetes have been published in the last two decades. We aimed to evaluate the hotspots and future trends in GWAS in diabetes research through bibliometric analysis. Accordingly, 567 research and review articles published between 2001 and 2021 were included. A rising trend was noted in the annual number of publications and citations on GWAS in diabetes during this period. Harvard University and Harvard Medical School have played leading roles in genome research. Hotspot analyses indicated that DNA methylation and genetic variation, especially in type 2 diabetes mellitus, are likely to remain the research hotspots. Moreover, the identification of genetic phenotypes associated with adiposity, metabolic memory, pancreatic islet, and inflammation is the leading trend in this research field. Through this review, we provide predictions on the main research trends in the future so as to shed light on new directions and ideas for further investigations on the genetic etiology of diabetes for its prevention and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Characteristics of Interferon-Associated Diabetes Mellitus in Past 30 Years: A Review.
- Author
-
Wang, Linghuan, Chen, Kang, Wang, Meirong, Lv, Zhaohui, Gu, Weijun, Wang, Xianling, Ni, Qi, and Mu, Yiming
- Subjects
CELL receptors ,TYPE 2 diabetes ,TYPE 1 diabetes ,DIABETES ,ANTIVIRAL agents ,HISTOCOMPATIBILITY antigens - Abstract
Interferon (IFN) is a broad-spectrum antiviral agent that activates cell surface receptors and causes cells to produce antiviral proteins, inhibiting viral replication. Interferon use has long been associated with diabetes. The PubMed database was searched for articles related to diabetes and interferon from March 30, 2020. Patients were divided into type 1 diabetes group and type 2 diabetes group. We reviewed the relevant literature to compare interferon-associated T1D and interferon-associated T2D differences. Interferon treatment shortened the incubation period of T2D and changed the original T2D to T1D. The onset of interferon-associated T1D required longer periods of IFN treatment than interferon-associated T2D, and the interferon-associated T1D group had higher GADA positive rates, lower BMI, lower fasting blood glucose, and greater insulin dependence (p<0.05). More patients in the T1D group were positive for HLA-DRB1*04, DRB1*03, DRB1*09, DRB1*14, HLA-DQB1*04, HLA-DQB1*02, HLA-DQB1*03, and HLA-DQB1*05. The combined detection of GAD antibodies and HLA alleles may be an effective method to predict the incidence of T1D after IFN treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Glucose‐lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology.
- Author
-
Hong, Tianpei, Su, Qing, Li, Xiaoying, Shan, Zhongyan, Chen, Li, Peng, Yongde, Chen, Liming, Yan, Li, Bao, Yuqian, Lyu, Zhaohui, Shi, Lixin, Wang, Weiqing, Guo, Lixin, Ning, Guang, Mu, Yiming, and Zhu, Dalong
- Subjects
TYPE 2 diabetes ,HEART failure ,CHRONIC kidney failure ,CARDIOVASCULAR diseases ,GLUCAGON-like peptide 1 ,EXPERT evidence ,CARDIOVASCULAR diseases risk factors - Abstract
Patients with type 2 diabetes mellitus (T2DM) are at risk of developing atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD), which are important causes of disabling and death in patients with T2DM. For the prevention and management of ASCVD or CKD, cardiovascular risk factors should be systematically evaluated, and ASCVD and CKD should be screened in patients with T2DM. In this consensus, we recommended that metformin should be used as the first‐line therapy for patients with T2DM and ASCVD or very high cardiovascular risk, heart failure (HF) or CKD, and should be retained in the treatment regimen unless contraindicated or not tolerated. In patients with T2DM and established ASCVD or very high cardiovascular risk, addition of a glucagon‐like peptide 1 receptor agonist (GLP‐1RA) or sodium–glucose cotransporter type 2 (SGLT2) inhibitor with proven cardiovascular benefits should be considered independent of individualised glycated haemoglobin (HbA1C) targets. In patients with T2DM and HF, an SGLT2 inhibitor should be preferably added regardless of HbA1C levels. In patients with T2DM and CKD, SGLT2 inhibitors should be preferred for the combination therapy independent of individualised HbA1C targets, and GLP‐1RAs with proven renal benefits would be alternative if SGLT2 inhibitors are contraindicated. Moreover, the prevention of hypoglycaemia and management of multiple risk factors by comprehensive regimen, including lifestyle intervention, antihypertensive therapies, lipid‐lowering treatment and antiplatelet therapies, should be kept in mind in treating patients with T2DM and ASCVD, HF or CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Association Between Perioperative Glycemic Control Strategy and Mortality in Patients With Diabetes Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.
- Author
-
Jin, Xinye, Wang, Jinjing, Ma, Yanfang, Li, Xueqiong, An, Ping, Wang, Jie, Mao, Wenfeng, Mu, Yiming, Chen, Yaolong, and Chen, Kang
- Subjects
GLYCEMIC control ,CARDIAC surgery ,PEOPLE with diabetes ,ATRIAL fibrillation ,WOUND infections - Abstract
Objective: To analyze association between different perioperative glycemic control strategies and postoperative outcomes in patients with diabetes undergoing cardiac surgery. Methods: MEDLINE, Cochrane Library, Web of Science, EMBASE, Wanfang Data, China National Knowledge Infrastructure (CNKI) and China Biology Medicine (CBM) databases were searched from inception to January 31, 2019. Two researchers independently screened the literature, extracted data, and evaluated the risk of bias of included studies, and consensus was reached by discussion with a third researcher. Results: Six RCTs were included in the meta-analysis. We analyzed the effect of liberal (>180 mg/dl or 10.0 mmol/L), moderate (140–180 mg/dl or 7.8–10.0 mmol/L) and strict (<140 mg/dl or 7.8 mmol/L) glycemic control strategies in patients with diabetes undergoing cardiac surgery. The pooled results showed that strict glycemic control strategy was associated with a significant reduction in the risk of atrial fibrillation [OR = 0.48, 95%CI (0.32, 0.72), P < 0.001] and sternal wound infection [OR = 0.28, 95%CI (0.14, 0.54), P < 0.001], while there was no significant differences in postoperative mortality, stroke, and hypoglycemic episodes when compared with moderate control. In addition, there is no significant difference between moderate and liberal glycemic control strategies in postoperative mortality. However, moderate control was beneficial in reducing atrial fibrillation [OR = 0.28, 95%CI (0.13, 0.60), P = 0.001] compared with the liberal glycemic control strategy. Conclusions: This meta-analysis showed when compared with moderate glycemic control strategy in patients with diabetes undergoing cardiac surgery, maintained strict glycemic control was associated with lower risk of atrial fibrillation and sternal wound infection. No benefit was found with liberal glycemic control strategy, so it could be a poor glycemic control strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. Effect of different types of anesthesia on intraoperative blood glucose of diabetic patients
- Author
-
Li, Xueqiong, Wang, Jinjing, Chen, Kang, Li, Yijun, Wang, Haibin, Mu, Yiming, and Chen, Yaolong
- Subjects
meta-analysis ,Blood Glucose ,diabetes ,Diabetes Mellitus ,blood glucose control ,Humans ,Anesthesia ,Systematic Review and Meta-Analysis ,Research Article - Abstract
Background: Systematic review which analyzes the impact of different anesthesia on intraoperative blood glucose levels of diabetes patients. Methods: We searched Medline (via PubMed), Embase, Cochrane Library, Web of Science, Wangfang, CNKI, and CBM database through June 2016, included in randomized controlled trial (RCT), about different anesthesia on intraoperative blood glucose levels in patients with diabetes. Two researchers in 1 group independently screened literatures with eligibility criteria, extracted information, and used RevMan5.3 software to perform meta-analysis. Results: We included 11 trials and performed the meta-analysis with 10 trials. The meta-analysis results suggested that compared with general anesthesia, the combined general-epidural anesthesia has a better glycemic control in intraoperative blood glucose levels (WMD −1.26, 95% confidence interval [CI] −1.77 to 0.76), the epidural anesthesia had no significant effects compared with general anesthesia (WMD −0.74, 95% CI 4.41–2.92), and the combined spinal-epidural anesthesia had no significant effects compared with epidural anesthesia (WMD −0.28, 95% CI −1.02 to 0.46). One study suggested that compared with epidural anesthesia, the combined general-epidural anesthesia can lower blood glucose levels Conclusion: Existing evidence showed that compared with general anesthesia, the combined general-epidural anesthesia has a better glycemic control in intraoperative blood glucose levels.
- Published
- 2017
21. Insulin resistance is associated with urinary albumin‐creatinine ratio in normal weight individuals with hypertension and diabetes: The REACTION study.
- Author
-
Gu, Shi, Wang, Anping, Ning, Guang, Zhang, Linxi, and Mu, Yiming
- Subjects
INSULIN resistance ,BLOOD pressure ,BODY mass index ,DIABETES ,HYPERTENSION - Abstract
Copyright of Journal of Diabetes is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2020
- Full Text
- View/download PDF
22. Association between birth weight and diabetes: Role of body mass index and lifestyle in later life.
- Author
-
Hu, Chunyan, Mu, Yiming, Wan, Qin, Qin, Yingfen, Hu, Ruying, Shi, Lixin, Su, Qing, Yu, Xuefeng, Yan, Li, Qin, Guijun, Tang, Xulei, Chen, Gang, Gao, Zhengnan, Wang, Guixia, Shen, Feixia, Luo, Zuojie, Chen, Li, Huo, Yanan, Li, Qiang, and Ye, Zhen
- Subjects
- *
BIRTH weight , *BODY mass index , *GLUCOSE tolerance tests , *LOW birth weight , *DIABETES - Abstract
Background: This study investigated the association between birth weight and diabetes in a Chinese population, and the effects of body mass index (BMI) and lifestyle factors in later life on this association. Methods: Data from 49 118 participants aged ≥40 years with recalled birth weight from the Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study, a nationwide population‐based cohort, were used. Diabetes diagnosis was based on oral glucose tolerance tests and HbA1c measurements. Logistic regression models were used to evaluate the association of birth weight and risk of diabetes in later life. Results: Increased risk of diabetes was associated with lower or higher birth weight. Compared with individuals with a birth weight of 2500 to 3499 g, the odds ratios (ORs) and 95% confidence intervals (CIs) of diabetes for individuals with a birth weight of <2500, between 3500 and 3999, and ≥4000 g were 1.28 (1.11‐1.47), 1.11 (1.04‐1.19), and 1.20 (1.07‐1.34), respectively. Significant associations were prominent in participants with a current BMI ≥24 kg/m2, but not detected in those with a normal BMI (OR 1.20 [95% CI 0.96‐1.49], 1.11 [95% CI 0.98‐1.25], and 1.10 [95% CI 0.89‐1.37], respectively). Moreover, there was no increased risk of diabetes in individuals with a low birth weight but with healthy dietary habits (OR 0.94; 95% CI 0.68‐1.29) or ideal physical activity (OR 1.41; 95% CI 0.97‐2.04). Conclusions: A U‐shaped association was observed between birth weight and the risk of diabetes. Healthy lifestyles (healthy dietary habits or ideal physical activity) may eliminate the negative effects of low birth weight in the development of diabetes, but not the effect of high birth weight. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
23. Quality Assessment of Systematic Review of the Bariatric Surgery for Diabetes Mellitus.
- Author
-
Jin, Xinye, Wang, Jinjing, Li, Xueqiong, An, Ping, Wang, Haibin, Mao, Wenfeng, Zhou, Qi, Chen, Yaolong, Wang, Jie, Chen, Kang, and Mu, Yiming
- Subjects
BARIATRIC surgery ,META-analysis ,DIABETES ,GREY literature ,PUBLICATION bias - Abstract
Objective. Using the AMSTAR tool, this study evaluated the quality of systematic reviews (SRs) that assessed the efficacy of bariatric surgery in diabetic patients. We aimed to identify studies that can be used as clinical references. Methods. Medline (via PubMed), EMBASE, Epistemonikos, Web of Science, Cochrane Library, CBM, CNKI, and Wanfang Data were systematically searched from inception to December 31, 2017. Two reviewers independently selected SRs and extracted data. Disagreements were solved by discussions or through consultation with a third reviewer. Reviewers extracted data (characteristics of included SRs, e.g., publication year, language, and number of authors) into the predefined tables in the Microsoft Excel 2013 sheet. Data were visualized using the forest plot in RevMan 5.3 software. Results. A total of 64 SRs were included. The average AMSTAR score was 7.4±1.7. AMSTAR scores of 7 (n=21, 32.8%) and 8 (n=14, 28.1%) were most common. The AMSTAR scores of SRs published before 2016 (n=46, 71.9%) were compared with SRs published after 2016 (n=18, 28.1%), and no significant differences were observed (MD=−0.79, 95% confidence interval (CI) -1.65-0.07, P=0.07). For SRs published in Chinese (n=17, 26.6%) compared to those published in English (n=47, 73.4%), the AMSTAR scores significantly differed (MD=0.21, 95% CI (-0.55, 0.97), P=0.59). For SRs published in China (n=33, 51.6%) compared to those published outside of China (n=31, 48.4%), significant differences in the AMSTAR scores were observed (MD=1.10, 95% CI (0.29, 1.91), P=0.008). For SRs with an author number≤6 (n=31, 48.4%) compared to SRs with authors≥6 (n=33, 51.6%), no significant differences were observed (MD=−0.36, 95% CI (-1.22, 0.50), P=0.41). For high-quality SRs published after 2016 (n=11, 17.2%) compared to other SRs (n=53, 82.8%), statistically significant differences were noted (MD=1.75, 95% CI (1.01, 2.49), P<0.00001). Conclusions. The number of SRs assessing the efficacy of bariatric surgery in diabetic patients is increasing by year, but only a small number meet the criteria to support guideline recommendations. Study protocols not being registered, grey literature not retrieved, incorporation of grey literature as exclusion criteria, and failure to evaluate publication bias and report a conflict of interest were the main causes of low AMSTAR scores. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Neutrophil‐lymphocyte ratio as a predictor of kidney function decline among individuals with diabetes and prediabetes: A 3‐year follow‐up study.
- Author
-
Li, Jia, Li, Tong, Wang, Haibin, Yan, Wenhua, and Mu, Yiming
- Subjects
FOLLOW-up studies (Medicine) ,DIABETES ,KIDNEYS ,RATIO & proportion - Abstract
Highlights This study is the first study to confirm that the neutrophil–lymphocyte ratio (NLR) is an independent predictive factor for kidney function decline among individuals with diabetes and prediabetes. Calculating the NLR is easy and inexpensive, so we believe that with more research support the NLR will be used as an effective indicator in the clinical management of individuals with diabetes and prediabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. Association between Duration of Exercise (MET Hours per Week) and the Risk of Decreased eGFR: A Cross-Sectional Study Based on a Large Chinese Population.
- Author
-
Wang, Jie, Li, Yijun, Chen, Kang, Yan, Wenhua, Wang, Anping, Wang, Weiqing, Gao, Zhengnan, Tang, Xulei, Yan, Li, Wan, Qin, Luo, Zuojie, Qin, Guijun, Chen, Lulu, and Mu, Yiming
- Subjects
LOGISTIC regression analysis ,CROSS-sectional method ,GLOMERULAR filtration rate ,PHYSICAL activity ,EXERCISE ,EXERCISE intensity ,DIABETES - Abstract
Background. Physical activity is effective in preventing chronic diseases. However, the impact of different durations of exercise on human health is unknown, especially among people with diabetes or prediabetes. Objective. To explore the relationship between high MET hours per week and the change in glomerular filtration rate (eGFR) in the total population and different subgroups. Methods. A total of 43767 individuals from eight provinces, in China, were recruited. Logistic analysis was used to investigate the association. Participants were divided into 3 groups based on MET hours per week. The primary outcome was an eGFR≤90 mL/min/1.73 m
2 . Results. The average eGFR was 100.10 (92.43-106.43) mL/min/1.732 . Logistic regression analysis revealed that more than 7.5 MET hours per week (equivalent to more than 150 minutes of moderate-intensity of exercise) was associated with the higher risk of the decreased eGFR even after adjusting for confounding factors (7.5 to <21: OR=1.18, 95% CI [1.09, 1.29]; ≥21: OR=1.12, 95% CI [1.05, 1.19], p for trend: 0.0047). After adjusting for confounding factors, in stratified analyses, there still existed a significant relationship among participants aged from 55 to less than 65 years, but not among participants younger than 55 or older than 65 years. Similarly, there existed a positive association between high MET hours per week and the decreased eGFR in participants without diabetes and prediabetes, but not in participants with diabetes or prediabetes, and the interactions of age and diabetic states were found. However, there was no significant difference in women or men. Conclusions. More than 7.5 MET hours per week (equivalent to more than 150 minutes per week or 60 minutes per day of moderate-intensity exercise) was associated with decreased eGFR among participants aged from 55 to less than 65 years and participants without diabetes and prediabetes, but not among participants aged younger than 55 years and older than 65 years and participants with diabetes or prediabetes. The importance of planning individualized physical activities is highlighted. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
26. Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes.
- Author
-
Yin, Yaqi, Ye, Sisi, Wang, Haibin, Li, Bing, Wang, Anping, Yan, Wenhua, Dou, Jingtao, and Mu, Yiming
- Subjects
GLYCEMIC control ,DIABETES ,TYPE 2 diabetes ,HEMOGLOBINS ,BLOOD sugar - Abstract
Background: The red cell distribution width (RDW) has been shown to be associated with the incidence and complications of type 2 diabetes (T2D). However, the relevance of RDW with the risk of being in poor glycemic control among patients with established T2D is largely overlooked. Methods: A total of 702 T2D participants from the REACTION study were enrolled in this study. Blood routine index, fasting plasma glucose, hemoglobin A1c and lipid profile data were available for all of the enrolled population. Results: The univariate logistic analysis revealed a significant association between RDW and the risk of being in poor glycemic control among T2D subjects with an odds ratio (OR) and a 95% confidence interval (CI) of 0.5 and 0.3-0.8, respectively, for the fourth vs the first quartile of RDW. The association strengthened after multivariable adjustment (OR [95% CI]: 0.3 [0.2-0.7]). Interaction and stratified analyses indicated that this association was seen only among T2D subjects with lower body mass index and/or serum lipid levels. Conclusion: T2D patients with higher RDW had significantly lower risk of being in poor glycemic control. RDW may contribute to risk assessment for T2D individuals at risk of being in poor glycemic control. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
27. Mild hyperglycemia triggered islet function recovery in streptozotocin-induced insulin-deficient diabetic rats.
- Author
-
Cheng, Yu, Shen, Jing, Ren, Weizheng, Hao, Haojie, Xie, Zongyan, Liu, Jiejie, Mu, Yiming, and Han, Weidong
- Subjects
DIABETIC nephropathies ,DIABETES complications ,INSULIN ,PEOPLE with diabetes ,DIABETES ,HYPOGLYCEMIC agents ,INSULIN therapy ,GLUCOSE clamp technique - Abstract
Aims/Introduction Moderate elevation of glucose level has been shown to effectively promote β-cell replication in various models in vitro and in normal rodents. Here, we aimed to test the effect of moderately elevated glucose on β-cell mass expansion and islet function recovery in diabetic animal models. Materials and Methods A single high dose of streptozotocin was given to induce insulin-deficient diabetes in adult male Sprague-Dawley rats. Then, 48 h after streptozotocin injection, newly diabetic rats were randomly divided into three groups: (i) no treatment to maintain hyperglycemia; (ii) daily exogenous long-acting human insulin analog injection that maintained mild hyperglycemia (15 mmol/L < blood glucose < 18 mmol/L); (iii) daily exogenous long-acting human insulin analog injection to restore normoglycemia (blood glucose <8 mmol/L) as a control. Islet function, β-cell regeneration and β-cell replication were monitored during the entire analysis period. Results A single high dose of streptozotocin induced massive loss of β-cells, resulting in irreversible hyperglycemia. Mild hyperglycemia markedly promoted β-cell proliferation, leading to robust β-cell regeneration. Importantly, rats that maintained mild hyperglycemia showed nearly normal glucose-stimulated insulin secretion, glucose disposal and random blood glucose levels, suggesting almost full restoration of the islet function. Normalization of blood glucose levels profoundly blunted β-cell replication, regeneration and islet function recovery observed in mild hyperglycemia. Conclusions Our research provides a feasible approach to stimulate in situ β-cell regeneration in diabetic rats, offering new perspectives for diabetes therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
28. Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: a longitudinal ( REACTION) study (队列简介:中国糖尿病患者肿瘤发生风险的纵向研究(REACTION研究))
- Author
-
Bi, Yufang, Lu, Jieli, Wang, Weiqing, Mu, Yiming, Zhao, Jiajun, Liu, Chao, Chen, Lulu, Shi, Lixin, Li, Qiang, Wan, Qin, Wu, Shengli, Yang, Tao, Yan, Li, Liu, Yan, Wang, Guixia, Luo, Zuojie, Tang, Xulei, Chen, Gang, Huo, Yanan, and Gao, Zhengnan
- Subjects
GLUCOSE ,MONOSACCHARIDES ,CANCER in women ,GENES ,BLOOD plasma - Abstract
Copyright of Journal of Diabetes is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2014
- Full Text
- View/download PDF
29. Insulin pump therapy guidelines for China (July 2010).
- Author
-
MU, Yiming and YIN, Shinan
- Subjects
- *
INSULIN pumps , *INSULIN , *HYPERGLYCEMIA treatment , *QUALITY of life , *PATIENT compliance - Abstract
The article offers information on the guidelines for insulin pump therapy guidelines in China that was released in July 2010. It states that the said therapy refers to the administration of insulin via continuous subcutaneous infusion to stimulate physiological insulin secretion to control hyperglycemia. It mentions that the use of insulin pump can improve patient's quality of life in terms of treatment compliance as well as the ability to control blood glucose level.
- Published
- 2012
- Full Text
- View/download PDF
30. Glycemic status and chronic kidney disease in Chinese adults: Findings from the REACTION study.
- Author
-
Lin, Lin, Lu, Jieli, Chen, Lulu, Mu, Yiming, Ye, Zhen, Liu, Chao, Chen, Gang, Shi, Lixin, Zhao, Jiajun, Li, Qiang, Yang, Tao, Yan, Li, Wan, Qin, Wu, Shengli, Liu, Yan, Wang, Guixia, Luo, Zuojie, Tang, Xulei, Huo, Yanan, and Gao, Zhengnan
- Subjects
KIDNEY diseases ,DIABETES risk factors ,GLYCEMIC index ,CHINESE people ,PREDIABETIC state ,DISEASES - Abstract
Copyright of Journal of Diabetes is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2017
- Full Text
- View/download PDF
31. Beta-cell regeneration from vimentin+/MafB+ cells after STZ-induced extreme beta-cell ablation.
- Author
-
Cheng, Yu, Kang, Hongjun, Shen, Jing, Hao, Haojie, Liu, Jiejie, Guo, Yelei, Mu, Yiming, and Han, Weidong
- Subjects
PANCREATIC beta cells ,DIABETES ,REGENERATION (Biology) ,STREPTOZOTOCIN ,INSULIN ,PROGENITOR cells - Abstract
Loss of functional beta-cells is fundamental in both type 1 and type 2 diabetes. In situ beta-cell regeneration therefore has garnered great interest as an approach to diabetes therapy. Here, after elimination of pre-existing beta cells by a single high-dose of streptozotocin (STZ), we demonstrated that a considerable amount of beta-like-cells was generated within 48 hrs. But the newly formed insulin producing cells failed to respond to glucose challenge at this time and diminished afterwards. Insulin treatment to normalize the glucose level protected the neogenic beta-like cells and the islet function was also gradually matured. Strikingly, intermediate cells lacking epithelial marker E-cadherin but expressing mesenchymal cell-specific marker vimentin appeared within 16 hrs following STZ exposure, which served as the major source of insulin-producing cells observed at 24 hrs. Moreover, these intermediate cells strongly expressed alpha-cell-specific marker MafB. In summary, the data presented here identified a novel intermediate cell type as beta-cell progenitors, showing mesenchymal cell feature as well as alpha-cell marker MafB. Our results might have important implications for efforts to stimulate beta-cell regeneration. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
32. Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis.
- Author
-
Song, Xiaoyan, Jia, Hetang, Jiang, Yuebo, Wang, Liang, Zhang, Yan, Mu, Yiming, and Liu, Yu
- Subjects
GLUCAGON-like peptide 1 ,DIABETES ,BRAIN natriuretic factor ,FIBRINOLYTIC agents ,MUSCLE cells - Abstract
This study assessed the effect of GLP-1 based therapies on atherosclerotic markers in type 2 diabetes patients. 31 studies were selected to obtain data after multiple database searches and following inclusion and exclusion criteria. Age and BMI of the participants of longitudinal studies were 59.8 ± 8.3 years and 29.2 ± 5.7 kg/m
2 (Mean±SD). Average duration of GLP-1 based therapies was 20.5 weeks. Percent flow-mediated diameter (%FMD) did not change from baseline significantly but when compared to controls, %FMD increased non-significantly following GLP-1-based therapies (1.65 [−0.89, 4.18]; P = 0.2; REM) in longitudinal studies and increased significantly in cross sectional studies (2.58 [1.68, 3.53]; P < 0.00001). Intima media thickness decreased statistically non-significantly by the GLP-1 based therapies. GLP-1 based therapies led to statistically significant reductions in the serum levels of brain natriuretic peptide (−40.16 [−51.50, −28.81]; P < 0.0001; REM), high sensitivity c-reactive protein (−0.27 [−0.48, −0.07]; P = 0.009), plasminogen activator inhibitor-1 (−12.90 [−25.98, 0.18]; P=0.05), total cholesterol (−5.47 [−9.55, −1.39]; P = 0.009), LDL-cholesterol (−3.70 [−7.39, −0.00]; P = 0.05) and triglycerides (−16.44 [−25.64, −7.23]; P = 0.0005) when mean differences with 95% CI in the changes from baselines were meta-analyzed. In conclusion, GLP-1-based therapies appear to provide beneficial effects against atherosclerosis. More randomized data will be required to arrive at conclusive evidence. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.